The study conducted by Tan and colleagues on HD patients demonstrated that the transcription factor HUGO: GTF2A1 appears to be dysregulated in competing endogenous RNA network interaction and is associated with transcriptional activation. This evidence concerns the gene GTF2A1 and Huntington disease.